Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06051539
Other study ID # PS300
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 10, 2023
Est. completion date September 2025

Study information

Verified date October 2023
Source MedRhythms, Inc.
Contact Cecilia Carlowicz, MPH
Phone 207-200-4482
Email ccarlowicz@medrhythms.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this trial is to assess engagement, efficacy, durability, and impact on health care resource utilization of MR-001 in persons with chronic stroke who have a gait deficit after in-home/community use.


Description:

This is a decentralized clinical trial designed to assess clinical outcomes and resulting healthcare resource utilization (HCRU) of MedRhythms' MR-001 device used by patients with chronic stroke in the home setting. MR-001 is an autonomous neurorehabilitation system based on the principles of Rhythmic Auditory Stimulation intended to improve walking in adult chronic stroke patients. MR-001 is a prescription medical device intended for use at home. The user operates the device autonomously and the therapy progresses automatically once a user engages in a session. The MR-001 system consists of two foot sensors that measure walking, a locked touchscreen device preloaded with a proprietary software application, a headset, and charging equipment. The electronic components are powered by lithium-ion rechargeable batteries. The primary objective of this study is to assess engagement with MR-001 walking therapy in chronic stroke patients with a gait deficit in a real world setting. The primary endpoint will be measured by session completion over the 12 week intervention period. Secondary endpoints include assessing effect on walking endurance, durability of response, and reintroduction of the intervention, as well as effect on healthcare resource utilization.


Recruitment information / eligibility

Status Recruiting
Enrollment 225
Est. completion date September 2025
Est. primary completion date January 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: 1. Equal to or greater than 6 months post-stroke with gait impairment 2. Age >/= 18 - 85 years of age, inclusive 3. Understand and speak English 4. Must be able to ambulate without assistance from another person. Note: assistive devices are allowed. If a participant uses an assistive device at the time of enrollment, the device must be used for all walking sessions. 5. Willing to travel to a Velocity location to complete in-person gait assessments 6. Able to walk at a speed greater than or equal to 0.4 m/s as derived as an average of speed per minute from the 6MWT. Note: if a participant intends to use an assistive device throughout the intervention period, the assistive device must be used during the gait assessment. 7. Must have claims data available and consent to sharing. Exclusion Criteria: 1. Hearing impairment with or without the use of hearing aids such that the participant cannot hear the rhythmic stimulation of the music 2. Pain that impairs walking ability 3. Unable to safely participate in walking sessions as determined by investigator 4. Requires more than one rest (seated or not) during the 6MWT 5. Significant comorbid medical or neurological conditions that could impact gait or prevent safe participation as determined by the Investigator. For example: condition that prevents participation in exercise, e.g., Parkinson's disease, cerebral palsy, multiple sclerosis, myasthenia gravis, muscular dystrophy, or spinal cord injury. Note: major surgery within the last 3 months is exclusionary. 6. People who are pregnant or become pregnant (due to expected gait pattern changes). 7. Lower limb prosthetic 8. More than 2 falls in the previous month 9. Non-reciprocal gait pattern. Note: Note: a non-reciprocal gait pattern is defined as a 3-point step pattern. Participants must have a 2-point step pattern to qualify. Asymmetry seen in gait is acceptable. 10. Treatment with a gait-based investigational intervention within the last 3 months. 11. Unable or unwilling to provide informed consent to participate

Study Design


Related Conditions & MeSH terms


Intervention

Device:
MR-001
MR-001 is an autonomous neurorehabilitation system based on the principles of Rhythmic Auditory Stimulation intended to improve walking and ambulation in adult chronic stroke patients. MR-001 is intended to be a prescription use only device for use at home/community. The user operates the MR-001 System autonomously and the therapy progresses automatically once a user engages in a session. The MR-001 system consists of two foot sensors that measure walking, a touchscreen device preloaded solely with a proprietary software application, a headset, and charging equipment. The electronic components are powered by lithium-ion rechargeable batteries. Participants are asked to walk with the device for 3 times per week for 12 weeks. Each walking session is 30 minutes in length.

Locations

Country Name City State
United States Curavit Clinical Research - DECENTRALIZED CLINICAL TRIAL Portland Maine

Sponsors (1)

Lead Sponsor Collaborator
MedRhythms, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other 6 Minute Walk Test (6MWT) To assess change in walking endurance of persons who are re-introduced to a second round of treatment with the intervention 12 weeks
Other Timed Up and Go (TUG) To assess change in mobility after 12 weeks of intervention 12 weeks
Other Timed Up and Go (TUG) To assess change in mobility of persons who are re-introduced to a second round of treatment with the intervention 12 weeks
Other All-cause HCRU To assess change in all-cause healthcare resource utilization 52 weeks
Other All-cause hospitalizations and emergency department visits To assess change in all-cause hospitalizations and emergency department visits 52 weeks
Primary Number of walking sessions during 12-week intervention period The purpose of this study is to assess engagement with MR-001 walking therapy in chronic stroke patients with a gait deficit in a real world setting. Engagement will be measured as number of walking sessions observed across the 12 week intervention period. 12 weeks
Secondary 6 Minute Walk Test (6MWT) To assess whether MR-001 improves walking endurance 12 weeks
Secondary 6 Minute Walk Test (6MWT) To assess durability of response to MR-001 after 12 weeks of intervention 12 weeks
Secondary Patient Health Questionnaire-8 (PHQ-8) To assess whether MR-001 improves health-related quality of life in chronic stroke patients with gait deficit 24 weeks
Secondary The Barthel Index To assess whether MR-001 improves activities of daily living in chronic stroke patients with gait deficit 24 weeks
Secondary PROMIS Social Isolation Scale To assess whether MR-001 improves social isolation in patients with chronic stroke with gait deficit 24 weeks
Secondary Trail Making Tests A & B To assess whether MR-001 improves cognition and executive in patients with chronic stroke with gait deficit 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT03780296 - Implementing Technology Enhanced Real Time Action Observation Therapy in Persons With Chronic Stroke N/A
Not yet recruiting NCT06057584 - Effect of Somatosensory Motor Intergration Training on Post-stroke Upper Limb Function. N/A
Completed NCT03228264 - A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia. N/A
Completed NCT03531567 - Game-Based Home Exercise Programs in Chronic Stroke: A Feasibility Study N/A
Completed NCT02364232 - Effects of Home-based vs. Clinic-based Rehabilitation on Sensorimotor, Cognition, Daily Function, and Participation N/A
Completed NCT04121754 - Post-Stroke Walking Speed and Community Ambulation Conversion Study N/A
Completed NCT04574687 - Effects of Action Observation Therapy on Fine Motor Skills of Upper Limb Functions in Chronic Stroke Patients. N/A
Recruiting NCT04974840 - Thera-band Resisted Treadmill Training for Chronic Stroke Patients N/A
Recruiting NCT04534556 - Wireless Nerve Stimulation Device To Enhance Recovery After Stroke N/A
Completed NCT04553198 - Quantifying the Role of Sensory Systems Processing in Post-Stroke Walking Recovery N/A
Completed NCT04226417 - Effect of Home Based Transcranial Direct Current Stimulation (tDCS) With Exercise on Upper and Lower Limb Motor Functions in Chronic Stroke N/A
Recruiting NCT06049849 - Can Patients With Chronic Stroke Regain Living Independence by Daily Energizing With Biophoton Generators N/A
Active, not recruiting NCT02881736 - Proprioceptive Deficits and Anomalies in Movement-error Processing in Chronic Stroke Patients N/A
Completed NCT03208634 - Rehabilitation Multi Sensory Room for Robot Assisted Functional Movements in Upper-limb Rehabilitation in Chronic Stroke N/A
Completed NCT05183100 - Effects of Neurodynamics on Lower Extremity Spasticity - a Study in Chronic Stroke N/A
Completed NCT03326349 - Home-based Computerized Cognitive Rehabilitation in Chronic Stage Stroke N/A
Recruiting NCT04721860 - Optimizing Training in Severe Post-Stroke Walking Impairment N/A
Not yet recruiting NCT06060470 - Active Balance and Cardio Care Intervention on Physical and Cardiovascular Health in People With Chronic Stroke N/A
Recruiting NCT05591196 - Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke N/A
Recruiting NCT06116942 - Magnetic Brain Stimulation and Computer-based Motor Training for Rehabilitation After Stroke N/A